Breaking News

Today
Show Full Stories

X

To view all stories in expanded form, please subscribe.
Send Info
ITCI

Intra-Cellular

$15.32

0.26 (1.73%)

09:26
11/20/17
11/20
09:26
11/20/17
09:26
Technical Analysis
Technical View: Intra-Cellular up on FDA Fast Track designation for lumateperone »

In the pre-market the…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 28

    Nov

MDSO

Medidata

$68.64

-0.85 (-1.22%)

08:32
11/20/17
11/20
08:32
11/20/17
08:32
Hot Stocks
Medidata, MEL MEDICAL announce multi-year Medidata eTMF agreement »

Medidata announced that…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 28

    Nov

PRTA

Prothena

$51.93

-2.88 (-5.25%)

07:49
11/20/17
11/20
07:49
11/20/17
07:49
Downgrade
Prothena rating change  »

Prothena downgraded to…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 27

    Nov

  • 28

    Nov

  • 29

    Nov

AFAM

Almost Family

$61.85

0.65 (1.06%)

, LHCG

LHC Group

$67.65

-0.28 (-0.41%)

07:32
11/20/17
11/20
07:32
11/20/17
07:32
Downgrade
Almost Family, LHC Group rating change at RBC Capital »

Almost Family downgraded…

AFAM

Almost Family

$61.85

0.65 (1.06%)

LHCG

LHC Group

$67.65

-0.28 (-0.41%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 12

    Dec

  • 13

    Dec

AFAM

Almost Family

$61.85

0.65 (1.06%)

07:20
11/20/17
11/20
07:20
11/20/17
07:20
Downgrade
Almost Family rating change at RBC Capital »

Almost Family downgraded…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

AGRX

Agile Therapeutics

$4.57

0.1 (2.24%)

07:16
11/20/17
11/20
07:16
11/20/17
07:16
Recommendations
Agile Therapeutics analyst commentary at Cantor Fitzgerald »

Cantor still sees high…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 26

    Dec

ITCI

Intra-Cellular

$15.32

0.26 (1.73%)

07:05
11/20/17
11/20
07:05
11/20/17
07:05
Hot Stocks
Intra-Cellular receives FDA Fast Track designation for lumateperone »

Intra-Cellular announced…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 28

    Nov

PRTA

Prothena

07:00
11/20/17
11/20
07:00
11/20/17
07:00
Downgrade
Prothena rating change at Wedbush »

Prothena downgraded to…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 27

    Nov

  • 28

    Nov

  • 29

    Nov

QHC

Quorum Health

$4.60

0.09 (2.00%)

06:56
11/20/17
11/20
06:56
11/20/17
06:56
Hot Stocks
Quorum Health receives outstanding payments from Illinois, California »

Quorum Health announced…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

Friday
XENE

Xenon Pharmaceuticals

, AMGN

Amgen

$170.77

1.39 (0.82%)

14:29
11/17/17
11/17
14:29
11/17/17
14:29
Periodicals
Xenon higher as CNBC's Tirrell reports on nonaddictive pain medicines »

Six drug companies are…

XENE

Xenon Pharmaceuticals

AMGN

Amgen

$170.77

1.39 (0.82%)

RHHBY

Roche

$28.90

0.165 (0.57%)

BIIB

Biogen

$313.98

3.7 (1.19%)

RGEN

Repligen

$33.73

1.12 (3.43%)

VRTX

Vertex

$147.94

-0.72 (-0.48%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 28

    Nov

  • 30

    Nov

  • 30

    Nov

  • 02

    Dec

  • 23

    Dec

  • 03

    Feb

  • 23

    Feb

  • 30

    Apr

  • 17

    May

  • 28

    May

Get Full Fly Access

Breaking market intelligence sent straight to you
Our team of experts analyze every news story and filter out the noise to deliver real-time market moving news.
Up-to-date information on important industry events
Get real-time updates on events that are moving the market—from conferences and calls to syndicate announcements.
News focused on the companies in your portfolio
Create up to 12 portfolios with 150 stocks each, and see how active they are in market news.